CDSCO Panel grants Pfizer's Protocol Amendment for Anti-cancer Drug Palbociclib study Dr. Divya Colin16 March 2024 4:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Anti emetic efficacy of Low dose Olanzapine non-Inferior to high dose in patients with Solid tumors Aditi25 Jan 2024 3:00 AM ISTOlanzapine is an effective antiemetic medication, but it can cause significant drowsiness when taken at the standard dose.According to a study...
Progression-free survival in advanced melanoma improved by Cell therapy Isra Zaman12 Sept 2022 9:45 AM ISTA novel treatment strategy with personalized cell therapy significantly improves progression-free survival compared to standard immunotherapy in...
New CAR T-cell therapy for solid tumors was safe and showed early efficacy Dr. Kamal Kant Kohli29 April 2022 9:00 AM ISTNEW ORLEANS: A new chimeric antigen receptor (CAR) T-cell product had an acceptable safety profile and showed early signs of efficacy as a monotherapy...
